About Teva India Private Limited
Data last updated:
Teva India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Teva Pharmaceutical Investments Singapore Pte. Ltd.. It operates in the technical services segment of the professional services sector. It was incorporated on 13 December 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2000PTC405989. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹18.43 Cr and a paid-up capital of ₹12.56 Cr. It was formerly known as Ivax India Private Limited. It is led by directors including Avani Kishorbhai Kansara and Nishank Bhargava.
Its last annual general meeting (AGM) was held on 25 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol, Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2026, the company reported a revenue of ₹4.98 Cr. For the same year it recorded a net profit of ₹3.71 Cr (net margin 74.5%) and EBITDA of ₹4.96 Cr (EBITDA margin 99.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 15% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹15.49 Cr; the latest was in September 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tevapharm.com.
Company details
CIN history
Teva India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100MH2000PTC405989, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100MH2000PTC405989 | Current |
| U73100DL2000PTC268473 | Previous |
| U73100MH2000PTC130011 | Previous |
Contact details
Teva India Private Limited's registered office is in Mumbai, Maharashtra. Its website is tevapharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol, Mumbai, Maharashtra, India – 400059
- IndustryProfessional Services, Technical, Personal, Scientific
To see the full contact details of Teva India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Teva India Private Limited
FY 2026 filings availableTeva India Private Limited reported revenue of ₹4.98 Cr for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹4.98 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.96 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.6% | ||||
| Net Profit Margin | 74.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Teva India Private Limited, buy the company report.
Board of directors of Teva India Private Limited
Teva India has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avani Kishorbhai Kansara Also directs: Teva Healthcare India Private Limited | Director | 19 Jun 2025 | 1 Years 4 Months | Current |
| Nishank Bhargava Also directs: Watson Pharma Private Limited, Actavis Pharma Development Centre Private Limited, Tevapharm India Private Limited and 1 more | Director | 28 Mar 2022 | 4 Years 7 Months | Current |
| Fabian Jude Dsouza | Director | 26 Jul 2016 | 10 Years 3 Months | Current |
Auditor
Teva India Private Limited is audited by Arora & Arora for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Arora & Arora | FY 2026 | 100544W |
Shareholding
The shareholding of Teva India Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Teva India Private Limited, buy the company report.
Deals & funding
Teva India Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹15.49 Cr; the latest was in September 2019.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2019 | Secondary share transfer | Undisclosed | Seller: Teva Pharmaceutical Investment Singapore Pte Limited |
| Jun 2008 | Funding round | ₹9.63 Cr | Investors: Teva Pharmaceutical Investment Singapore Pte Limited |
To see the full deal history of Teva India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Teva India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Teva India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Teva India Private Limited has a workforce of 2 employees on its EPFO records as of Sep 2017, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2017-18 | 2 |
| FY 2016-17 |
To see the full employee and EPFO history of Teva India Private Limited, buy the company report.
GST
Teva India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Teva India Private Limited, buy the company report.
Recent activity
Teva India Private Limited has 19 board changes on record since 2007: 3 appointments and 16 cessations. The latest: Avani Kishorbhai Kansara ceased to be Additional Director on 24 Aug 2025.
10 earlier events are in the company report.
News
Frequently asked questions
Teva India is an active private limited company based in Mumbai, Maharashtra, India. The company works in technical, within the professional services industry. It was incorporated on 13 December 2000 (26+ years old) and is registered under CIN U73100MH2000PTC405989.
Teva India has 3 current directors:
- Avani Kishorbhai Kansara - Director
- Nishank Bhargava - Director
- Fabian Jude Dsouza - Director
The latest financial statements of Teva India on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 August 2025. Year-wise statements from 2015 are in the company report.
No. Teva India has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Teva India is U73100MH2000PTC405989. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teva India was incorporated on 13 December 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Teva India has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹15.49 Cr; the latest was in September 2019.
Avani Kishorbhai Kansara ceased to be Additional Director on 24 Aug 2025. Avani Kishorbhai Kansara was appointed as Director on 19 Jun 2025. Nishank Bhargava ceased to be Additional Director on 17 Aug 2022. Teva India has 19 board changes on record in total.
Teva India can be reached through the website tevapharm.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Teva India is at 8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol, Mumbai, Maharashtra, India – 400059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
